Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ameren Illinois (AILIM) EBITDA (2016 - 2025)

Historic EBITDA for Ameren Illinois (AILIM) over the last 17 years, with Q3 2025 value amounting to $641.0 million.

  • Ameren Illinois' EBITDA rose 4057.02% to $641.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 2473.5%. This contributed to the annual value of $1.2 billion for FY2024, which is 303.82% up from last year.
  • Latest data reveals that Ameren Illinois reported EBITDA of $641.0 million as of Q3 2025, which was up 4057.02% from $273.0 million recorded in Q2 2025.
  • In the past 5 years, Ameren Illinois' EBITDA registered a high of $641.0 million during Q3 2025, and its lowest value of $139.0 million during Q4 2021.
  • Over the past 5 years, Ameren Illinois' median EBITDA value was $258.0 million (recorded in 2024), while the average stood at $295.4 million.
  • Examining YoY changes over the last 5 years, Ameren Illinois' EBITDA showed a top increase of 5838.93% in 2021 and a maximum decrease of 1516.39% in 2021.
  • Ameren Illinois' EBITDA (Quarter) stood at $139.0 million in 2021, then increased by 7.19% to $149.0 million in 2022, then increased by 5.37% to $157.0 million in 2023, then surged by 35.03% to $212.0 million in 2024, then skyrocketed by 202.36% to $641.0 million in 2025.
  • Its EBITDA stands at $641.0 million for Q3 2025, versus $273.0 million for Q2 2025 and $286.0 million for Q1 2025.